Small-molecule screening made simple for a difficult target with a signaling nucleic acid aptamer that reports on deaminase activity.

[1]  D. Patel,et al.  Adaptive recognition by nucleic acid aptamers. , 2000, Science.

[2]  R. Hosmane,et al.  A unique ring-expanded acyclic nucleoside analogue that inhibits both adenosine deaminase (ADA) and guanine deaminase (GDA; guanase): synthesis and enzyme inhibition studies of 4,6-diamino-8H-1-hydroxyethoxymethyl-8-iminoimidazo[4,5-e][1,3]diazepine. , 2001, Bioorganic & medicinal chemistry letters.

[3]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[4]  Yingfu Li,et al.  Structure-switching signaling aptamers. , 2003, Journal of the American Chemical Society.

[5]  Robert A Copeland,et al.  Mechanistic considerations in high-throughput screening. , 2003, Analytical biochemistry.

[6]  Razvan Nutiu,et al.  Signaling Aptamers for Monitoring Enzymatic Activity and for Inhibitor Screening , 2004, Chembiochem : a European journal of chemical biology.

[7]  C. Chung,et al.  Effect of detergent on "promiscuous" inhibitors. , 2003, Journal of medicinal chemistry.

[8]  C. Morimoto,et al.  Direct association of adenosine deaminase with a T cell activation antigen, CD26. , 1993, Science.

[9]  J. Ungerer,et al.  Kinetic determination of serum adenosine deaminase. , 1993, Clinical chemistry.

[10]  Amy C Yan,et al.  Protein-dependent ribozymes report molecular interactions in real time , 2002, Nature Biotechnology.

[11]  E. Brown,et al.  Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. , 2004, Chemistry & biology.

[12]  B. Shoichet,et al.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.

[13]  M. Aldrich,et al.  The importance of adenosine deaminase for lymphocyte development and function. , 2000, Biochemical and biophysical research communications.

[14]  J. Szostak,et al.  A DNA aptamer that binds adenosine and ATP. , 1995, Biochemistry.

[15]  M. Bessodes,et al.  Adenosine deaminase inhibitors. Conversion of a single chiral synthon into erythro- and threo-9-(2-hydroxy-3-nonyl)adenines. , 1981, Journal of Medicinal Chemistry.

[16]  B. Sullenger,et al.  Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.

[17]  Eric D. Brown,et al.  High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase , 2004, Chemistry & Biology.

[18]  Ji-Hu Zhang,et al.  Probing the Primary Screening Efficiency by Multiple Replicate Testing: A Quantitative Analysis of Hit Confirmation and False Screening Results of a Biochemical Assay , 2005, Journal of biomolecular screening.

[19]  E. Brown,et al.  High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate. , 2003, Bioorganic & medicinal chemistry letters.

[20]  A D Ellington,et al.  Aptamers as therapeutic and diagnostic reagents: problems and prospects. , 1997, Current opinion in chemical biology.

[21]  M. Kurz,et al.  ADP-specific sensors enable universal assay of protein kinase activity. , 2004, Chemistry & biology.

[22]  Ronald R. Breaker,et al.  Natural and engineered nucleic acids as tools to explore biology , 2004, Nature.

[23]  Takayoshi Kinoshita,et al.  A highly potent non-nucleoside adenosine deaminase inhibitor: efficient drug discovery by intentional lead hybridization. , 2004 .

[24]  J. Linden.  Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.

[25]  Nadine H. Elowe,et al.  Experimental Screening of Dihydrofolate Reductase Yields a “Test Set” of 50,000 Small Molecules for a Computational Data-Mining and Docking Competition , 2005, Journal of biomolecular screening.